Pfizer stock is trading -19.75% below its average target price of $32.66 after marking a 1.5% during today's afternoon session. Analysts are giving the Large-Cap Pharmaceutical company an average rating of buy and target prices ranging from $25.0 to $45.0 per share.
The stock has a very low short interest at 1.7%, and a short ratio of 2.07. At 0.05%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation. Finally, we also note that an average number of institutional investors are invested in the stock, with 67.8% of Pfizer's shares being owned by this investor type.
Institutions Invested in Pfizer
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2024-09-30 | Vanguard Group Inc | 9% | 516,249,875 | $13,530,908,751 |
2024-09-30 | Blackrock Inc. | 8% | 436,001,294 | $11,427,593,516 |
2024-09-30 | State Street Corporation | 5% | 290,460,600 | $7,612,972,060 |
2024-09-30 | Wellington Management Group, LLP | 3% | 163,727,320 | $4,291,292,907 |
2024-09-30 | Charles Schwab Investment Management, Inc. | 2% | 130,143,942 | $3,411,072,600 |
2024-09-30 | Geode Capital Management, LLC | 2% | 117,666,245 | $3,084,032,173 |
2024-06-30 | Norges Bank Investment Management | 1% | 83,963,188 | $2,200,675,080 |
2024-09-30 | Morgan Stanley | 1% | 77,971,216 | $2,043,625,499 |
2024-09-30 | Massachusetts Financial Services Co. | 1% | 71,151,857 | $1,864,890,106 |
2024-09-30 | State Farm Mutual Automobile Insurance Co | 1% | 54,508,560 | $1,428,669,307 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Pfizer.